The presence of leukocytes in ex vivo assays significantly increases the 50-percent inhibitory concentrations of artesunate and chloroquine against Plasmodium vivax and Plasmodium...

by S. Kaewpongsri, K. Sriprawat, R. Suwanarusk, D. E. Kyle, U. Lek-Uthai, M. Leimanis, K. M. Lwin, A. P. Phyo, J. Zwang, B. Russell, F. Nosten, L. Renia
Published 2018

Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax

by R. Suwanarusk, M. Chavchich, B. Russell, A. Jaidee, F. Chalfein, M. Barends, B. Prasetyorini, E. Kenangalem, K. A. Piera, U. Lek-Uthai, N. M. Anstey, E. Tjitra, F. Nosten, Q. Cheng, R. N. Price
Published 2018

Stronger activity of human immunodeficiency virus type 1 protease inhibitors against clinical isolates of Plasmodium vivax than against those of P. falciparum

by U. Lek-Uthai, R. Suwanarusk, R. Ruengweerayut, T. S. Skinner-Adams, F. Nosten, D. L. Gardiner, P. Boonma, K. A. Piera, K. T. Andrews, B. MacHunter, J. S. McCarthy, N. M. Anstey, R. N. Price, B. Russell
Published 2018